Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TEVA-BUDESONIDE TEVA CANADA LIMITED Resolved 0.125MG Updated Report 2025-12-13 234891
TIMOPTIC ELVIUM LIFE SCIENCES Resolved 0.5% Updated Report 2025-12-13 267762
TARO-RAMIPRIL SUN PHARMA CANADA INC Resolved 2.5MG Updated Report 2025-12-13 273704
TARO-DEFERASIROX (TYPE J) TARO PHARMACEUTICALS INC Resolved 90MG Updated Report 2025-12-13 268841
LIDOCAINE HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Actual shortage 10MG Updated Report 2025-12-13 269025
REVATIO BGP PHARMA ULC Actual shortage 20MG Updated Report 2025-12-13 272461
NOVAMOXIN TEVA CANADA LIMITED Resolved 500MG Updated Report 2025-12-13 272751
INDIUM (111IN) OXINE SOLUTION GE HEALTHCARE CANADA INC Resolved 37MBq Updated Report 2025-12-13 273147
TARO-CLOBETASOL OINTMENT USP, 0.05% TARO PHARMACEUTICALS INC Resolved 0.05% Updated Report 2025-12-13 273673
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP GLENMARK PHARMACEUTICALS CANADA INC. Resolved 3MG 0.02MG Updated Report 2025-12-13 272444

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
TARO-CLOBETASOL OINTMENT USP, 0.05% TARO PHARMACEUTICALS INC Discontinued 0.05% Updated Report 2025-12-13 274315
CEFTRIAXONE SODIUM FOR INJECTION BP STERIMAX INC To be discontinued 250MG New Report 2025-12-11 274173
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP STERIMAX INC To be discontinued 7.5MG New Report 2025-12-11 274162
TRUSOPT ELVIUM LIFE SCIENCES Discontinued 2% Updated Report 2025-12-10 267941
FIASP NOVO NORDISK CANADA INC Discontinued 100UNIT Updated Report 2025-12-08 240240